Teva Announces Appointment of New Chief Financial Officer | BioSpace
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote - YouTube
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
Michael (Mickey) Ben Moshe - VP Finance, Corporate Treasury @ Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Teva | Partnership | Direct Relief
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Efi Benmeir - SVP Finance & CFO International Markets - Teva Pharmaceutical Industries Ltd. | LinkedIn
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva workers threaten to blow up Jerusalem factory in protest over layoffs | The Times of Israel
Teva Reports Third Quarter 2022 Financial Results
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
